Patients affected by Huntington's disease in India, alongside their caregivers and advocacy groups, are actively campaigning for the condition to be officially recognized as a "rare disease" under the National Policy for Rare Diseases (NPRD) 2021. This initiative also includes a significant push for the establishment of a national patient registry dedicated to Huntington's disease, aiming to enhance diagnosis, treatment access, and research efforts across the country. The unified appeal seeks to address current challenges faced by individuals living with this complex neurological disorder.

The primary motivation behind seeking rare disease status is to unlock crucial support mechanisms and resources outlined in the NPRD 2021. This policy provides a framework for financial assistance for treatment, encourages research and development of therapies, and aims to improve overall infrastructure for rare disease management. Currently, many Huntington's patients encounter significant hurdles, including diagnostic delays, limited access to specialized medical care, and the prohibitive cost of managing a progressive, incurable condition. Official recognition could alleviate some of these burdens by integrating Huntington's disease into national health strategies and funding programs.

A national patient registry is considered a vital tool in this advocacy. Such a registry would systematically collect comprehensive data on Huntington's disease patients, including demographic information, disease progression, genetic profiles, and treatment responses. This centralized data would serve multiple critical functions:

  • Accurate Prevalence Data: Provide a clearer understanding of the disease's incidence and prevalence in India, which is currently not well-documented.
  • Research Facilitation: Accelerate research initiatives by identifying cohorts for clinical trials and epidemiological studies.
  • Resource Allocation: Inform healthcare planning and resource allocation, enabling the government and healthcare providers to develop targeted support services and specialized clinics.
  • Early Diagnosis: Contribute to better diagnostic protocols by tracking symptom onset and progression, potentially leading to earlier intervention.

Huntington's disease is a genetic, progressive neurodegenerative disorder that impacts nerve cells in the brain, leading to uncontrolled movements, cognitive decline, and psychiatric problems. It is an inherited condition, meaning it is passed down through families. The Huntington's Disease Society of India (HDSI) is a key organization at the forefront of this advocacy, working to raise awareness, support patients, and lobby policymakers. They highlight the lack of awareness among medical professionals, which often results in misdiagnosis or delayed diagnosis, further exacerbating the challenges for patients and their families. The Centre for DNA Fingerprinting and Diagnostics (CDFD) in Hyderabad is noted as one of the facilities offering diagnostic testing, but access remains a barrier for many.

The ongoing advocacy reflects a broader movement within the rare disease community in India to ensure equitable access to care and support. Should Huntington's disease receive the rare disease tag and a registry be established, it could significantly improve the quality of life for affected individuals and contribute to global efforts to understand and ultimately treat this debilitating condition. The focus remains on government engagement to review the current policy framework and implement the necessary changes to include Huntington's disease within the designated rare disease categories.